<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04618159</url>
  </required_header>
  <id_info>
    <org_study_id>2018-380</org_study_id>
    <nct_id>NCT04618159</nct_id>
  </id_info>
  <brief_title>Does Helipyl Eradicate</brief_title>
  <acronym>Helipyl</acronym>
  <official_title>Does Helipyl Eradicate</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitair Ziekenhuis Brussel</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Helipyl is on the market; actually it is a post-biotic because it is a killed Lactobacillus&#xD;
      reuteri DSMZ 17648. The aim is to demonstrate (or not) that this product eradicates&#xD;
      helicobacter, which it claims to do.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a pilot project. There is quite limited literature on this product and Helicobacter&#xD;
      pylori eradication. My personal opinion is that the literature and guidelines are&#xD;
      contradictory. The European guideline is that Helicobacter pylori should not be corrected&#xD;
      unless there are &quot;serious&quot; symptoms . On the other hand, Helicobacter is a carcinogen. Quite&#xD;
      often, parents ask us, children's gastroenterologists, to screen their children for&#xD;
      Helicobacter because they are symptomatic and are being eradicated, and know that&#xD;
      Helicobacter is contagious. This creates a difficult situation: not answering the question is&#xD;
      not an option according to the parents' opinion. Going into the question and eradicating&#xD;
      &quot;classic&quot; is against all guidelines.&#xD;
&#xD;
      Hence this pilot project: 10 complaints-free carriers of Helicobacter pylori (&gt; 5 years) will&#xD;
      be treated with Helipyl for one month (product supplied by the company). Beforehand, at the&#xD;
      end of the treatment and a month after stopping of the treatment, we do a C13 breath test.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 10, 2019</start_date>
  <completion_date type="Actual">January 25, 2020</completion_date>
  <primary_completion_date type="Actual">June 1, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>helipyl is given to patients with non symptomatic helicobacter pylori infection</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>to evaluate the C13 breathtest</measure>
    <time_frame>6months</time_frame>
    <description>evaluation of C13 breathtest before, at the end of treatment and one month after treatment</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Eradication</condition>
  <arm_group>
    <arm_group_label>Helipyl</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>helipyl wil be given to 10 children with asymptomatical helicobacter pylori infection</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>lactobacillus reuteri DSMZ 17648</intervention_name>
    <description>to evaluate if this product can eradicate helicobacter pylori</description>
    <arm_group_label>Helipyl</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  &gt;5 and &lt;18 years&#xD;
&#xD;
          -  male and female&#xD;
&#xD;
          -  asymptomatic helicobacter pylori&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  helicobacter pylori infection with symptoms&#xD;
&#xD;
          -  &lt;5 years&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>UZ Brussel</name>
      <address>
        <city>Brussels</city>
        <state>Brussel Hoofdstedelijk Gewest</state>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>October 8, 2018</study_first_submitted>
  <study_first_submitted_qc>November 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2020</study_first_posted>
  <last_update_submitted>November 4, 2020</last_update_submitted>
  <last_update_submitted_qc>November 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitair Ziekenhuis Brussel</investigator_affiliation>
    <investigator_full_name>Yvan Vandenplas</investigator_full_name>
    <investigator_title>head of departement</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

